BackgroundThe sensitivity and specificity of selected antigen detection rapid diagnostic tests (AG-RDTs) for SARS-CoV-2 were determined in the unvaccinated population when the Delta variant was circulating. Viral loads, dynamics, symptoms and tissue tropism differ between Omicron and Delta.AimWe aimed to compare AG-RDT sensitivity and specificity in selected subgroups during Omicron vs Delta circulation.MethodsWe retrospectively paired AG-RDT results with PCRs registered in Czechia's Information System for Infectious Diseases from 1 to 25 December 2021 (Delta, n = 20,121) and 20 January to 24 February 2022 (Omicron, n = 47,104).ResultsWhen confirmatory PCR was conducted on the same day as AG-RDT as a proxy for antigen testing close to peak viral load, the average sensitivity for Delta was 80.4% and for Omicron 81.4% (p < 0.05). Sensitivity in vaccinated individuals was lower for Omicron (OR = 0.94; 95% confidence interval (CI): 0.87-1.03), particularly in reinfections (OR = 0.83; 95% CI: 0.75-0.92). Saliva AG-RDT sensitivity was below average for both Delta (74.4%) and Omicron (78.4%). Tests on the European Union Category A list had higher sensitivity than tests in Category B. The highest sensitivity for Omicron (88.5%) was recorded for patients with loss of smell or taste, however, these symptoms were almost 10-fold less common than for Delta. The sensitivity of AG-RDTs performed on initially asymptomatic individuals done 1, 2 or 3 days before a positive PCR test was consistently lower for Omicron compared with Delta.ConclusionSensitivity for Omicron was lower in subgroups that may become more common if SARS-CoV-2 becomes an endemic virus.

Department of Genetics and Microbiology Faculty of Science BIOCEV Charles University Prague Czechia

Department of Information and Knowledge Engineering Faculty of Informatics and Statistics Prague University of Economics and Business Prague Czechia

Department of Software Engineering Faculty of Information Technology Czech Technical University Prague Czechia

Department of Statistics and Probability Faculty of Informatics and Statistics Prague University of Economics and Business Prague Czechia

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czechia

Institute of Health Information and Statistics of the Czech Republic Prague Czechia

National Reference Laboratory for Influenza and Respiratory Viruses National Institute of Public Health Prague Czechia

These authors contributed equally to this article and share the first authorship

Zobrazit více v PubMed

Singanayagam A, Hakki S, Dunning J, Madon KJ, Crone MA, Koycheva A, et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect Dis. 2022;22(2):183-95. 10.1016/S1473-3099(21)00648-4 PubMed DOI PMC

Vicentini M, Venturelli F, Mancuso P, Bisaccia E, Zerbini A, Massari M, et al. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022. Euro Surveill. 2023;28(13):2200494. 10.2807/1560-7917.ES.2023.28.13.2200494 PubMed DOI PMC

Homza M, Zelena H, Janosek J, Tomaskova H, Jezo E, Kloudova A, et al. Performance of seven SARS-CoV-2 self-tests based on saliva, anterior nasal and nasopharyngeal swabs corrected for infectiousness in real-life conditions: a cross-sectional test accuracy study. Diagnostics (Basel). 2021;11(9):1567. 10.3390/diagnostics11091567 PubMed DOI PMC

Dinnes J, Sharma P, Berhane S, van Wyk SS, Nyaaba N, Domen J, et al. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2022;7(7):CD013705. PubMed PMC

European Commission (EC). EU health preparedness: A common list of COVID-19 rapid antigen tests. 16th update. Brussels: EC; 2022. Available from: https://web.archive.org/web/20220628121228/https://health.ec.europa.eu/system/files/2022-06/covid-19_rat_common-list_en_0.pdf

Kliegr T, Jarkovský J, Jiřincová H, Kuchař J, Karel T, Tachezy R. Role of population and test characteristics in antigen-based SARS-CoV-2 diagnosis, Czechia, August to November 2021. Euro Surveill. 2022;27(33):2100442. 10.2807/1560-7917.ES.2022.27.33.2200070 PubMed DOI PMC

Czech Radio. Pět PCR testů zdarma místo dvou. Ministerstvo chystá od příštího týdne změnu u testování. [Five PCR tests free instead of two. The ministry is preparing a change in testing from next week]. Prague: Czech Radio; 2022. Czech. Available from: https://www.irozhlas.cz/zpravy-domov/koronavirus-kolik-pcr-testu-zdarma-testy-covid-aktualne-cesko_2201111010_ako

National Institute of Health of the Czech Republic (SZU). Charakterizace viru SARS-CoV-2 v České republice dle diskriminačních PCR a celogenomové sekvenace 17.12.2021. [Characterisation of SARS-CoV-2 in Czechia according to discriminatory PCR and whole genome sequencing 17 December 2021]. Prague: SZU; 2021. Czech. Available from: https://web.archive.org/web/20211224173255/http://www.szu.cz/uploads/documents/szu/aktual/SARS_CoV_2_podrobna_zprava_2021_12_17.pdf

National Institute of Health of the Czech Republic (SZU). Charakterizace viru SARS-CoV-2 v České republice dle diskriminačních PCR a celogenomové sekvenace 24. 1. 2022 [Characterisation of SARS-CoV-2 in Czechia according to discriminatory PCR and whole genome sequencing 24 January 2022]. Prague: SZU; 2022. Czech. Available from: https://web.archive.org/web/20220125225720/http://www.szu.cz/uploads/documents/szu/aktual/SARS_CoV_2_podrobna_zprava_SZU_2022_01_24.pdf

National Institute of Health of the Czech Republic (SZU). SARS-Cov-2: epidemiologická a mikrobiologická situace v ČR 14. 2. 2022. [SARS-CoV-2: epidemiological and microbiological situation in the Czech Republic 14 February 2022]. Prague: SZU; 2022. Czech. Available from: https://web.archive.org/web/20220618102452/http://www.szu.cz/uploads/documents/szu/aktual/SARS_CoV_2_podrobna_zprava_SZU_2022_02_14.pdf

Komenda M, Panoška P, Bulhart V, Žofka J, Brauner T, Hak J, et al. Přehled aktuální situace v ČR. Onemocnění aktuálně (incidence-7-14-kraje). [Overview of the current situation in the Czech Republic. Disease Current (region-level incidence)]. Prague: Ministry of Health of the Czech Republic; 2022. Available from: https://onemocneni-aktualne.mzcr.cz/covid-19

European Centre for Disease Prevention and Control (ECDC). Reinfection with SARS-CoV-2: implementation of a surveillance case definition within the EU/EEA. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Reinfection-with-SARSCoV2-implementation-of-a-surveillance-case-definition.pdf

World Health Organization (WHO). WHO Emergency Use Listing for In vitro diagnostics (IVDs) detecting SARS‐CoV‐2. Geneva: WHO; 2022. Available from: https://extranet.who.int/pqweb/sites/default/files/documents/220607_EUL_SARS-CoV-2_product_list.pdf

Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. Hoboken: Wiley; 2003.

Seabold S, Perktold J. statsmodels: Econometric and statistical modeling with python. Proceedings of the 9th Python in Science Conference. 2010.

Hay JA, Kissler SM, Fauver JR, Mack C, Tai CG, Samant RM, et al. Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study. eLife. 2022;11:e81849. 10.7554/eLife.81849 PubMed DOI PMC

Flinck H, Kerimov D, Luukinen B, Seiskari T, Aittoniemi J. Evaluation of the Roche-SD Biosensor rapid antigen test: Antigen is not reliable in detecting SARS-CoV-2 at the early stage of infection with respiratory symptoms. Diagn Microbiol Infect Dis. 2022;102(4):115628. 10.1016/j.diagmicrobio.2021.115628 PubMed DOI PMC

Bekliz M, Adea K, Puhach O, Perez-Rodriguez F, Marques Melancia S, Baggio S, et al. Analytical sensitivity of eight different SARS-CoV-2 antigen-detecting rapid tests for Omicron-BA.1 variant. Microbiol Spectr. 2022;10(4):e0085322. 10.1128/spectrum.00853-22 PubMed DOI PMC

Puhach O, Adea K, Hulo N, Sattonnet P, Genecand C, Iten A, et al. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. Nat Med. 2022;28(7):1491-500. 10.1038/s41591-022-01816-0 PubMed DOI

Office for National Statistics (ONS). Coronavirus (COVID-19) Infection Survey technical article: analysis of reinfections of COVID-19: June 2021. Newport: ONS; 2021. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsurveytechnicalarticleanalysisofreinfectionsofcovid19/june2021

Woodbridge Y, Amit S, Huppert A, Kopelman NM. Viral load dynamics of SARS-CoV-2 Delta and Omicron variants following multiple vaccine doses and previous infection. Nat Commun. 2022;13(1):6706. 10.1038/s41467-022-33096-0 PubMed DOI PMC

Kam KQ, Maiwald M, Chong CY, Thoon KC, Nadua KD, Loo LH, et al. SARS-CoV-2 antigen rapid tests and universal screening for COVID-19 Omicron variant among hospitalized children. Am J Infect Control. 2023;51(3):255-60. 10.1016/j.ajic.2022.11.002 PubMed DOI PMC

Vihta KD, Pouwels KB, Peto TE, Pritchard E, House T, et al. Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom. Clin Infect Dis. 2022;76(3):e133-41. PubMed PMC

Marais G, Hsiao NY, Iranzadeh A, Doolabh D, Enoch A, Chu CY, et al. Saliva swabs are the preferred sample for Omicron detection. Medrxiv. 2021; .10.1101/2021.12.22.21268246 DOI

Komenda M, Panoška P, Bulhart V, Žofka J, Brauner T, Hak J, et al. COVID 19: Přehled aktuální situace v ČR. Onemocnění aktuálně (incidence-7-14-CR). [Overview of the current situation in the Czech Republic. Disease Current (incidence 7-14 Czech Republic)]. [Accessed: 2 May 2023]. Available from: https://onemocneni-aktualne.mzcr.cz/covid-19

World Health Organization (WHO). Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic Geneva; WHO; 2023. Available from: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic

Luptakova V, Tachecí B. iRozhlas.cz. 2022 [cited 2023 May 5]. Available from: https://www.irozhlas.cz/zivotni-styl/zdravi/testovani-konvalinka_2201272045_voj.

Puhach O, Meyer B, Eckerle I. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol. 2023;21(3):147-61. PubMed PMC

Developing molecular surveillance of SARS-CoV-2 in the Czech Republic (2021-2022)